Clinical Roundup Phase III pancreatic cancer study launched with OS primary endpoint for patients receiving MRI-guided ablative radiation therapy October 21, 2022Vol.48 No.38
Clinical Roundup Baylor study points to strategy to suppress prostate cancer growth October 21, 2022Vol.48 No.38
Clinical Roundup Researchers discover how bacteria make pancreatic cancer cells grow and move October 21, 2022Vol.48 No.38
Clinical Roundup Individuals with inflammatory breast cancer at higher risk of cancer spread to the brain October 14, 2022Vol.48 No.37
Clinical Roundup Allogene initiates first allogeneic CAR T phase II trial October 14, 2022Vol.48 No.37
Clinical Roundup Female cancer patients report less satisfaction, more challenges with cancer care October 14, 2022Vol.48 No.37
Clinical Roundup Wistar scientists identify link between mitochondria and pancreatic cancer risk October 14, 2022Vol.48 No.37
Clinical Roundup Phase II trial of Jemperli plus chemotherapy shows positive headline results in patients with metastatic NSCLC October 07, 2022Vol.48 No.36
Clinical Roundup Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies October 07, 2022Vol.48 No.36
Clinical Roundup Roswell Park-CIM study shows novel agent can overcome immune dysfunction in cancer October 07, 2022Vol.48 No.36
